With the increasing use of sodium–glucose cotransporter receptor-2 (SGLT2) inhibitors, clinicians should be aware that these medications can cause vulvar pruritus, rash, and candidiasis, which may be mistaken for LS. The gene discussed is SLC5A2; the disease is Candidiasis, Invasive.